Go to deals
Healthcare

Biosency has raised funds for further development

Biosency has completed a fundraising to develop a software for predictive diagnosis.

Biosency is a French MedTech company focused on changing the way clinicians and patients manage chronic obstructive pulmonary disease (COPD). The company provides innovative, connected and patient-focused remote monitoring solutions to analyze long-term trends of vital signs which are of critical importance to reduce readmission rates by adjusting medication.

Oaklins’ team in France acted as the exclusive advisor to Biosency.

Service
Funding, debt advisory & ECM
Parties

Talk to the deal team

 Véronique  Roth

Véronique Roth

Senior Advisor

Paris, France
Oaklins France

Related deals

Westminster Homecare has been acquired by Care at Home
Healthcare

Westminster Homecare has been acquired by Care at Home

The private shareholders of Westminster Homecare Ltd. have sold the company to Care at Home Services (South East) Ltd.

Learn more
RVC Medical IT has been acquired by NEXUS AG
Private Equity | Healthcare | TMT

RVC Medical IT has been acquired by NEXUS AG

Main Capital Partners B.V. has sold RVC Medical IT B.V. to NEXUS AG.

Learn more
SCS Computers has been acquired by MAPS Group
Healthcare | TMT

SCS Computers has been acquired by MAPS Group

The private shareholders of SCS Computers, an Italian software company specialized in the healthcare sector, have sold the company to MAPS Group.

Learn more